invokana™ film-coated tablets 100 mg
johnson & johnson international (singapore) pte ltd - canagliflozin hemihydrate 102mg eqv canagliflozin - tablet, film coated - 100 mg - canagliflozin hemihydrate 102mg eqv canagliflozin 100 mg
invokana™ film-coated tablets 300 mg
johnson & johnson international (singapore) pte ltd - canagliflozin hemihydrate 306mg eqv canagliflozin - tablet, film coated - 300 mg - canagliflozin hemihydrate 306mg eqv canagliflozin 300 mg
invokana 100mg tablets
napp pharmaceuticals ltd - canagliflozin hemihydrate - tablet - 100mg
invokana
janssen-cilag international nv - canagliflozin - diabetes mellitus, type 2 - drugs used in diabetes - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes.for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1.
invokana tablet
janssen inc - canagliflozin - tablet - 100mg - canagliflozin 100mg - sodium-glucose cotransporter 2 (sglt2) inhibitors
invokana tablet
janssen inc - canagliflozin - tablet - 300mg - canagliflozin 300mg - sodium-glucose cotransporter 2 (sglt2) inhibitors
invokana 300mg tablets
napp pharmaceuticals ltd - canagliflozin hemihydrate - tablet - 300mg
canagliflozin 100mg tablets
colorama pharmaceuticals ltd - canagliflozin hemihydrate - oral tablet - 100mg
canagliflozin 300mg tablets
colorama pharmaceuticals ltd - canagliflozin hemihydrate - oral tablet - 300mg
canagliflozin 100mg tablets
j m mcgill ltd - canagliflozin hemihydrate - oral tablet - 100mg